Emodin, as a mitochondrial uncoupler, induces strong decreases in adenosine triphosphate (ATP) levels and proliferation of B16F10 cells, owing to their poor glycolytic reserve
Authors:
Open Access
- 24 June 2019
- journal article
- research article
- Published by Wiley in Genes to Cells
- Vol. 24 (8) , 569-584
Abstract
Many types of cancer cells show a characteristic increase in glycolysis, which is called the “Warburg effect”. By screening plant extracts, we identified one that decreases cellular ATP levels and suppresses proliferation of malignant melanoma B16F10 cells, but not of non‐cancerous MEF cells. We revealed that its active ingredient is emodin, which showed strong anti‐proliferative effects on B16F10 cells both in vitro and in vivo. Moreover, we also found that emodin can function as a mitochondrial uncoupler. Consistently, three known mitochondrial uncouplers also displayed potent antiproliferative effects and preferential cellular ATP reduction in B16F10 cells, but not in MEF cells. These uncouplers provoked comparable mitochondrial uncoupling in both cell types, but they manifested dramatically different cellular effects. Namely, in MEF cells, these uncouplers induced three to five‐fold increases in glycolysis from the basal state, and this compensatory activation appeared to be responsible for the maintenance of cellular ATP levels. In contrast, B16F10 cells treated with the uncouplers showed less than a two‐fold enhancement of glycolysis, which was not sufficient to compensate for the decrease of ATP production. Together, these results raise the possibility that uncouplers could be effective therapeutic agents specifically for cancer cells with prominent “Warburg effect”.Keywords
This publication has 36 references indexed in Scilit:
- Emodin induces human T cell apoptosis in vitro by ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunctionActa Pharmacologica Sinica, 2013
- Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid LeukemiaCancer Cell, 2011
- Inhibition of Mutated, Activated BRAF in Metastatic MelanomaNew England Journal of Medicine, 2010
- Enhanced ATPase activities as a primary defect of mutant valosin‐containing proteins that cause inclusion body myopathy associated with Paget disease of bone and frontotemporal dementiaGenes to Cells, 2010
- Long-Term Metformin Use Is Associated With Decreased Risk of Breast CancerDiabetes Care, 2010
- Cisplatin OverdoseDrug Safety, 2009
- Improving cancer radiotherapy with 2-deoxy-d-glucose: phase I/II clinical trials on human cerebral gliomasInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1996
- Uncoupling effect of fungal hydroxyanthraquinones on mitochondrial oxidative phosphorylationChemico-Biological Interactions, 1987
- Dynein: A Protein with Adenosine Triphosphatase Activity from CiliaScience, 1965
- On the Origin of Cancer CellsScience, 1956